Dr. The shareholders of Reddy’s Laboratories have approved GV Prasad to re-appoint GV Prasad in the 41st annual general meeting of the company held on July 24, 2025 from January 30, 2026 to January 29, 2031 as co-Speaker and Managing Director for a period of 5 years. Based on the recommendation of the nomination, government and compensation committee, this re -application was initially approved by the Board of Directors on May 9, 2025.
| Details | Acquaintance |
|---|---|
| Reason for change | GV Prasad’s reconstruction as co-chairman and managing director |
| Re-reunit | Effective from January 30, 2026 |
| Duration | 5 years (January 30, 2026 to 29 January, 2031) |
| Relationship between directors | GV Prasad, the company’s president K is Satish Reddy’s brother -in -law |
Brief introduction to GV Prasad
GV Prasad, Dr. Reddy’s Laboratories are one of the promoters and are employed as co-chairman and managing director. He has a Bachelor of Engineering degree in Chemical Engineering from Illinois Institute of Technology in Chicago and MS in Industrial Administration from Purdue University in Indiaa. Has done
GV Prasad through research, innovation, transparency, business ethics and streamlined corporate structure through Dr. He has played an important role in shaping Reddy’s. His leadership has helped the company gain global recognition for scientific innovation, practices of progressive people and high standards of corporate governance. He is focused on increasing the company’s association with human aspects of health, advising leaders and running innovation in science, technology and digitization, as well as supporting the planets, purpose and interest of patients.
With the experience experience of over 36 years in the pharmaceutical industry, GV Prasad ensures that Dr. Reddy’s is well prepared for the future by estimating future trends and imagining the future of healthcare. He is also active in the board of public and private institutions such as the Indian School of Business (ISB) and the International Foundation for Research and Education. Additionally, he is a member of the McCinse Center for CEO Excellence and the Governing Body of the Institute of Public Health Sciences Hyderabad Society.
GV Prasad was included in India’s top 50 CEOs by Outlook magazine in 2017 and was recognized as one of the top 5 most valuable CEOs in India by Business World in 2016. He was also included in the ‘Medicine Maker 2018 Power List’ and was named India Business Leader of the Year by CNBC Asia in 2014 and 2015.
Shareholder approval
The renovation of GV Prasad was approved by shareholders with the required majority in the 41st AGM, which reflects the company’s trust in their leadership and attitude.
Regulatory compliance
The announcement has been made in compliance with SEBI (listing obligations and disclosure requirements) Regulation, 2015 Regulation 30 and SEBI Circle Number SEBI/HO/CFD/POD 2/P/0155 dated November 11, 2024.